Related Experiment Videos

Antioxidant enzymatic system and free radicals pathway in two different human cancer cell lines

C Porta1, M Moroni, P Guallini

  • 1Istituto di Terapia Medica, Università degli Studi di Pavia, I.R.C.C.S. Policlinico San Matteo, Italy. cporta@mbox.vol.it

Anticancer Research
|September 1, 1996
PubMed

Insights

Cancer cells resist oxidative damage differently. DND-1A cells show higher antioxidant enzyme activity and resistance to hydrogen peroxide (H2O2), unlike HeLa cells, impacting cancer treatment strategies.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Oncology

Background:

  • Cancer cells exhibit resistance to oxidative damage.
  • Understanding cellular antioxidant defense mechanisms is crucial for cancer therapy.

Purpose of the Study:

  • To compare oxidative stress responses in DND-1A and HeLa cancer cell lines.
  • To analyze key components of cellular antioxidant defense, including enzymes, lipid peroxidation, glutathione levels, and reactive oxygen species (ROS) production.

Main Methods:

  • Assessed superoxide dismutase (SOD) and glutathione peroxidase (GSHPx) activities.
  • Measured lipid peroxidation and glutathione levels (total, reduced, oxidized).
  • Evaluated ROS production stimulated by menadione and cell susceptibility to H2O2 and menadione toxicity.

Main Results:

  • DND-1A cells displayed higher SOD and GSHPx activity compared to HeLa cells.
  • HeLa cells showed a tenfold increase in menadione-stimulated ROS production and significantly lower glutathione levels.
  • HeLa cells were sensitive to H2O2 toxicity, while DND-1A cells were more sensitive to menadione toxicity.

Conclusions:

  • DND-1A and HeLa cancer cell lines exhibit distinct oxidative stress defense mechanisms.
  • Differences in antioxidant capacity and ROS production influence cellular responses to oxidative challenges.
  • These findings may inform the development of targeted cancer therapies based on cellular oxidative profiles.

Related Concept Videos